EP3283086A4 - Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome - Google Patents

Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome Download PDF

Info

Publication number
EP3283086A4
EP3283086A4 EP16780670.2A EP16780670A EP3283086A4 EP 3283086 A4 EP3283086 A4 EP 3283086A4 EP 16780670 A EP16780670 A EP 16780670A EP 3283086 A4 EP3283086 A4 EP 3283086A4
Authority
EP
European Patent Office
Prior art keywords
microbiome
therapeutics
conditions associated
functional features
derived diagnostics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16780670.2A
Other languages
German (de)
English (en)
Other versions
EP3283086A1 (fr
Inventor
Zachary APTE
Daniel Almonacid
Jessica RICHMAN
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3283086A1 publication Critical patent/EP3283086A1/fr
Publication of EP3283086A4 publication Critical patent/EP3283086A4/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
EP16780670.2A 2015-04-13 2016-04-13 Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome Pending EP3283086A4 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562146833P 2015-04-13 2015-04-13
US201562147334P 2015-04-14 2015-04-14
US201562147202P 2015-04-14 2015-04-14
US201562147077P 2015-04-14 2015-04-14
US201562147058P 2015-04-14 2015-04-14
PCT/US2016/027359 WO2016168354A1 (fr) 2015-04-13 2016-04-13 Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome

Publications (2)

Publication Number Publication Date
EP3283086A1 EP3283086A1 (fr) 2018-02-21
EP3283086A4 true EP3283086A4 (fr) 2019-04-24

Family

ID=57126305

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780670.2A Pending EP3283086A4 (fr) 2015-04-13 2016-04-13 Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome

Country Status (4)

Country Link
EP (1) EP3283086A4 (fr)
CN (1) CN107708715B (fr)
AU (1) AU2016250104B2 (fr)
WO (1) WO2016168354A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016250159A1 (en) * 2015-04-14 2017-11-09 Psomagen, Inc. Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
AU2016321348A1 (en) * 2015-09-09 2018-04-26 Psomagen, Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with thyroid health issues
WO2018094376A1 (fr) * 2016-11-21 2018-05-24 uBiome, Inc. Procédé et système pour caractériser une affection liée à une céphalée
WO2018112419A1 (fr) * 2016-12-15 2018-06-21 uBiome, Inc. Procédé et système pour caractériser des affections liées au régime alimentaire
WO2018112437A1 (fr) * 2016-12-15 2018-06-21 uBiome, Inc. Procédé et système pour caractériser des affections liées à une allergie et associées à des micro-organismes
EP3776285A4 (fr) * 2016-12-16 2022-03-09 Psomagen, Inc. Procédé et système destinés à la caractérisation d'états pathologiques apparentés à un microorganisme
US20190136288A1 (en) * 2017-11-06 2019-05-09 uBiome, Inc. Control processes for microorganism-related characterization processes
WO2020088596A1 (fr) * 2018-10-31 2020-05-07 Coyote Diagnostics Lab (Beijing) Co., Ltd. Méthodes, systèmes et nécessaires de prédiction de condition de naissance prématurée
WO2020131923A1 (fr) * 2018-12-17 2020-06-25 uBiome, Inc. Pipeline de normalisation automatique pour analyse de données
WO2022269598A1 (fr) * 2021-06-20 2022-12-29 Biotax Labs Ltd. Système et procédé de prédiction d'un problème de santé sur la base d'un échantillon biologique
CN117409978B (zh) * 2023-12-15 2024-04-19 贵州大学 一种疾病预测模型构建方法、系统、装置及可读存储介质
CN117771278A (zh) * 2024-02-26 2024-03-29 四川大学华西医院 Prevotella copri在制备治疗老年衰弱综合征的药物中的用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140065132A1 (en) * 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
WO2014053608A1 (fr) * 2012-10-03 2014-04-10 Metabogen Ab Identification d'une personne ayant un risque d'athérosclérose et de maladies associées par le microbiome intestinal de la personne et prévention de telles maladies
WO2015027116A1 (fr) * 2013-08-21 2015-02-26 The Regents Of The University Of California Motifs de métabolites pour le diagnostic et la prédiction de troubles affectant le cerveau et le système nerveux

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011022660A1 (fr) * 2009-08-21 2011-02-24 Puretech Ventures, Llc Procédés de diagnostic et de traitement de maladie associée au microbiome au moyen de paramètres de réseau d’interaction
ES2636439T3 (es) * 2011-03-09 2017-10-05 Regents Of The University Of Minnesota Composiciones y métodos para el trasplante de microbiota de colon
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
BR112015018625A2 (pt) * 2013-02-04 2017-09-19 Seres Therapeutics Inc composições e métodos
US10633714B2 (en) * 2013-07-21 2020-04-28 Pendulum Therapeutics, Inc. Methods and systems for microbiome characterization, monitoring and treatment
WO2015112352A2 (fr) * 2014-01-25 2015-07-30 uBiome, Inc. Procédé et système d'analyse du microbiome

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140065132A1 (en) * 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
WO2014053608A1 (fr) * 2012-10-03 2014-04-10 Metabogen Ab Identification d'une personne ayant un risque d'athérosclérose et de maladies associées par le microbiome intestinal de la personne et prévention de telles maladies
WO2015027116A1 (fr) * 2013-08-21 2015-02-26 The Regents Of The University Of California Motifs de métabolites pour le diagnostic et la prédiction de troubles affectant le cerveau et le système nerveux

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016168354A1 *

Also Published As

Publication number Publication date
EP3283086A1 (fr) 2018-02-21
AU2016250104A1 (en) 2017-11-09
WO2016168354A1 (fr) 2016-10-20
CN107708715A (zh) 2018-02-16
CN107708715B (zh) 2022-06-03
AU2016250104B2 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
EP3347495A4 (fr) Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé gastro-intestinale
EP3209803A4 (fr) Procédé et système de diagnostic et de thérapie fondés sur le microbiome
EP3283086A4 (fr) Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome
EP3317428A4 (fr) Procédé et système destinés à un essai diagnostique
EP3347496A4 (fr) Méthode et système de diagnostics dérivés du microbiome et traitements thérapeutiques pour la santé bucco-dentaire
EP3227878A4 (fr) Procédé et système de stationnement légal
EP3097211A4 (fr) Procédé et système d'analyse du microbiome
EP3164805A4 (fr) Procédé et système de révision sélective de documents
EP3149698A4 (fr) Procédé et système de géo-alignement d'images
EP3347367A4 (fr) Procédé et système de diagnostic et de thérapie dérivés du microbiome pour la vaginose bactérienne
EP3190864A4 (fr) Système de montage de composant et procédé de montage de composant
EP3357047A4 (fr) Système et procédé d'organisation de véhicules
EP3145720B8 (fr) Système et procédé d'impression
EP3346912A4 (fr) Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale
GB201408912D0 (en) Vehicle control system and method
EP3346910A4 (fr) Procédé et système pour diagnostics dérivés du microbiome et agents thérapeutiques contre l'eczéma
EP3283085A4 (fr) Procédé et système pour diagnostics et thérapies dérivés du microbiome pour affections associées à des éléments taxonomiques du microbiome
EP3126243A4 (fr) Système et procédé de diagnostic amélioré d'un système d'entraînement
EP3273648A4 (fr) Système et procédé
GB201402828D0 (en) Vehicle control system and method
EP3105965A4 (fr) Système et procédé de ré-hébergement de connexion
EP3327402A4 (fr) Système et procédé d'inspection
EP3190434A4 (fr) Procédé et système d'inspection de véhicule
EP3283650A4 (fr) Procédé et système pour la caractérisation, le diagnostic et le traitement dérivés du microbiome d'affections associées à des caractéristiques fonctionnelles
EP3283648A4 (fr) Méthode et système de diagnostic dérivé du microbiome et de traitement de problèmes thérapeutiques destinés à des problèmes de santé neurologiques

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/70 20180101ALI20181205BHEP

Ipc: G06F 19/24 20110101ALI20181205BHEP

Ipc: G06F 19/18 20110101AFI20181205BHEP

Ipc: A61K 35/741 20150101ALN20181205BHEP

Ipc: G16H 50/20 20180101ALI20181205BHEP

Ipc: G16H 50/50 20180101ALI20181205BHEP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: G16H0050500000

A4 Supplementary search report drawn up and despatched

Effective date: 20190322

RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/50 20180101AFI20190329BHEP

Ipc: A61K 35/741 20150101ALN20190329BHEP

Ipc: G16H 50/20 20180101ALI20190329BHEP

Ipc: G16H 50/70 20180101ALI20190329BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191022

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

D18D Application deemed to be withdrawn (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN